Drug class
Tricyclic antidepressant; non-selective monoamine reuptake inhibitor
Mechanism of action
Inhibits neuronal reuptake of noradrenaline and 5-hydroxytryptamine, with a greater effect on noradrenaline; also inhibits dopamine uptake. It has central and peripheral anticholinergic and antihistaminic activity.
General use cases
- Treatment of symptoms of depressive illness, particularly where an anxiolytic effect is also required; UK product information restricts use to patients intolerant of or unresponsive to alternative options because of serious toxicity in overdose
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
